Results 61 to 70 of about 230,574 (171)

Perspective in pharmacological management of Graves' hyperthyroidism and orbitopathy

, 2008
Drugs currently used for Graves' hyperthyroidism (thionamides) or for the major extrathyroidal expression of Graves' disease, Graves' , orbitopathy (systemic glucocorticoids with or without orbital radiotherapy), have limited effects on the autoimmune ...
Bartalena L., Tanda M. L., Lai A.
core   +1 more source

Thyroid associated orbitopathy

Indian Journal of Ophthalmology, 2012
Thyroid associated orbitopathy, also known as Graves′ orbitopathy, is typically a self-limiting autoimmune process associated with dysthyroid states.
Rajat Maheshwari, Ezekiel Weis
doaj   +1 more source

Frequencies of alleles and genotypes in Graves' patients with and without orbitopathy.

, 2014
Frequencies of alleles and genotypes in Graves' patients with and without orbitopathy.
Tomasz Bednarczuk (236555), Rafal Ploski (348433), Dorota Kula (236546), Beata Jurecka-Lubieniecka (236543), Konrad Szymanski (284261), Urszula Ambroziak (604383), Lidia Hyla-Klekot (604385), Andrzej Tukiendorf (313702), Kornelia Hasse-Lazar (604384), Zofia Kolosza (398869), Barbara Jarzab (2550385)   +10 more
core   +1 more source

Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab

European Thyroid Journal
Introduction: Secondary thyroid autoimmunity, especially Graves’ disease (GD), frequently develops in patients with multiple sclerosis (MS) following alemtuzumab treatment (ALTZ; anti-CD52). Thyroid eye disease (TED) can also develop, and rituximab (RTX;
Ilaria Muller, Sara Maioli, Mirco Armenti, Laura Porcaro, Nicola Currò, Elisabetta Iofrida, Lorenzo Pignataro, Jacopo Manso, Caterina Mian, Jens Geginat, Mario Salvi   +10 more
doaj   +1 more source

De-identified raw data for relationship between sociodemographic factors and Graves' orbitopathy

, 2018
Deidentified Raw Data for the research project "Relationship Between Sociodemographic Factors and Graves' Orbitopathy" separated into diagnosis based on ICD 9 codes.
Shortell, J (via Mendeley Data), Shortell, Justin D   +1 more
core   +1 more source

Surgical Treatment of Graves’ Orbitopathy

, 2023
Abstract Surgical treatment for patients with Graves’ orbitopathy consists of orbital decompression, strabismus surgery and eyelid surgery. In this chapter, we will limit ourselves to orbital decompression (refer for strabismus surgery: Chap. 6 and for eyelid surgery: Chap.
Mourits, Maarten P., Gooris, Peter J. J., Bergsma, J. Eelco   +2 more
openaire   +2 more sources

RNFL Study in Graves Orbitopathy

, 2010
Purpose:to determine changes of retinal nerve fiber layer (RNFL) in a group of patients with serious thyroid-related immune orbitopathy and compare it with a group of patients with moderate Graves orbitopathy.
CAMPANERUT, SARA, AZZOLINI, CLAUDIO, SIVELLI, PAOLO, DONATI, SIMONE, CHELAZZI, PAOLO   +4 more
core  

Prevention of Graves' Orbitopathy: Early Diagnosis of Thyroid-Associated Orbitopathy in Graves' Disease [PDF]

Orbit, 2008
In spite of 200 years of research, the pathogenesis of Graves' orbitopathy (GO) remains an enigma.
openaire   +3 more sources

Late recurrence of unilateral graves orbitopathy on the contralateral side

, 2002
PURPOSE: To report a case of late recurrence of unilateral Graves orbitopathy on the contralateral side after 7 years. DESIGN: Interventional case report.
Mourits, Maarten P., Kalmann, Rachel, MS Oogheelkunde, Infection & Immunity   +3 more
core  

Graves′ orbitopathy: Management of difficult cases

Indian Journal of Endocrinology and Metabolism, 2012
Management of Graves′ ophthalmopathy (GO) is based on three pillars: to stop smoking, to restore and maintain euthyroidism, and to treat the eye changes according to severity and activity of GO.
Wilmar M Wiersinga
doaj   +1 more source